These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 27189785)
1. Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells. Kay NE; Sassoon T; Secreto C; Sinha S; Shanafelt TD; Ghosh AK; Arbiser JL Leuk Lymphoma; 2016 Oct; 57(10):2409-16. PubMed ID: 27189785 [TBL] [Abstract][Full Text] [Related]
2. The MEK1/2 inhibitor, MEKi-1, induces cell death in chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment and is synergistic with fludarabine. Crassini K; Stevenson WS; Mulligan SP; Best OG Leuk Lymphoma; 2015; 56(12):3407-17. PubMed ID: 25804768 [TBL] [Abstract][Full Text] [Related]
3. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways. Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567 [TBL] [Abstract][Full Text] [Related]
4. Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells. Paiva C; Godbersen JC; Soderquist RS; Rowland T; Kilmarx S; Spurgeon SE; Brown JR; Srinivasa SP; Danilov AV PLoS One; 2015; 10(11):e0143685. PubMed ID: 26606677 [TBL] [Abstract][Full Text] [Related]
5. Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia. Sivina M; Hartmann E; Vasyutina E; Boucas JM; Breuer A; Keating MJ; Wierda WG; Rosenwald A; Herling M; Burger JA Leukemia; 2012 Aug; 26(8):1812-20. PubMed ID: 22460735 [TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG. Ghosh AK; Kay NE; Secreto CR; Shanafelt TD Clin Cancer Res; 2009 Feb; 15(4):1250-8. PubMed ID: 19228728 [TBL] [Abstract][Full Text] [Related]
8. Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes. Filip AA; Ciseł B; Wąsik-Szczepanek E Clin Exp Med; 2015 Feb; 15(1):73-83. PubMed ID: 24337970 [TBL] [Abstract][Full Text] [Related]
10. DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells. Horie R; Watanabe M; Okamura T; Taira M; Shoda M; Motoji T; Utsunomiya A; Watanabe T; Higashihara M; Umezawa K Leukemia; 2006 May; 20(5):800-6. PubMed ID: 16525497 [TBL] [Abstract][Full Text] [Related]
11. Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide. Zolnierczyk JD; Błoński JZ; Robak T; Kiliańska ZM; Wesierska-Gadek J Ann N Y Acad Sci; 2009 Aug; 1171():124-31. PubMed ID: 19723046 [TBL] [Abstract][Full Text] [Related]
12. Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors. Sinha S; Boysen J; Nelson M; Secreto C; Warner SL; Bearss DJ; Lesnick C; Shanafelt TD; Kay NE; Ghosh AK Clin Cancer Res; 2015 May; 21(9):2115-26. PubMed ID: 25673699 [TBL] [Abstract][Full Text] [Related]
13. Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia. Balakrishnan K; Burger JA; Fu M; Doifode T; Wierda WG; Gandhi V Neoplasia; 2014 Dec; 16(12):1036-46. PubMed ID: 25499217 [TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia. Jewell AP Leuk Lymphoma; 1996 Mar; 21(1-2):43-7. PubMed ID: 8907268 [TBL] [Abstract][Full Text] [Related]
15. Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma. de la Puente P; Azab F; Muz B; Luderer M; Arbiser J; Azab AK Leuk Lymphoma; 2016 Jul; 57(7):1677-86. PubMed ID: 26421357 [TBL] [Abstract][Full Text] [Related]
16. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia. Bosanquet AG; Sturm I; Wieder T; Essmann F; Bosanquet MI; Head DJ; Dörken B; Daniel PT Leukemia; 2002 Jun; 16(6):1035-44. PubMed ID: 12040435 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes prosurvival stimuli to induce apoptosis in chronic lymphocytic leukemia cells. Cosimo E; McCaig AM; Carter-Brzezinski LJ; Wheadon H; Leach MT; Le Ster K; Berthou C; Durieu E; Oumata N; Galons H; Meijer L; Michie AM Clin Cancer Res; 2013 May; 19(9):2393-405. PubMed ID: 23532892 [TBL] [Abstract][Full Text] [Related]
18. Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemia. Consoli U; El-Tounsi I; Sandoval A; Snell V; Kleine HD; Brown W; Robinson JR; DiRaimondo F; Plunkett W; Andreeff M Blood; 1998 Mar; 91(5):1742-8. PubMed ID: 9473241 [TBL] [Abstract][Full Text] [Related]
19. AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance. Balakrishnan K; Burger JA; Wierda WG; Gandhi V Blood; 2009 Jan; 113(1):149-53. PubMed ID: 18836097 [TBL] [Abstract][Full Text] [Related]
20. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Campàs C; Cosialls AM; Barragán M; Iglesias-Serret D; Santidrián AF; Coll-Mulet L; de Frias M; Domingo A; Pons G; Gil J Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]